PIROXICAM TEVA 20 mg, hard capsule 15 capsules
Active ingredients: Piroxicam
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule15 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PIROXICAM TEVA 20 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC PVDC aluminium de 15 gélule(s)
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 4 Oct 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65592763CIP73611566CIP133400936115668Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PIROXICAMgélule | 20 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.